Demand for Precise and Effective Treatment Accelerating Stereotactic Planning Software Spending Analysis Market Growth: FMI
Published by mark itwired
Posted on September 20, 2021
5 min readLast updated: February 5, 2026

Published by mark itwired
Posted on September 20, 2021
5 min readLast updated: February 5, 2026

The stereotactic planning software market is set to grow at 4.6% CAGR by 2031, driven by demand for minimally-invasive treatments and rising neurological disorders.

The global stereotactic planning software spending analysis market is forecast to expand at 4.6% CAGR between 2021 and 2031, as per ESOMAR-certified consulting firm Future Market Insights (FMI).
According to the World Health Organization (WHO), in India around 1.9% of people over the age of 60 years are suffering from dementia. Considering the large size of population and rapid demographic changes, the total numbers are expected to reach 6 million by the end of 2040.
Increasing demand for minimally-invasive treatment options has fueled the adoption of stereotactic planning software. With the help of stereotactic planning software, surgeons will be able to perform surgery with reduced trajectory planning time.
COVID-19 pandemic hindered the stereotactic planning software spending market amid implementation of lockdown, limited production, and travel restrictions. Constant mutation in coronavirus is further straining the healthcare facilities severely delaying the treatment procedures for other ailments.
As social distancing was made mandatory, patient footfall in hospitals reduced unless they were availing emergency services in hospitals. These factors led to decline in stereotactic planning software market.
Recovery is on the horizon as pandemic is subsiding and restoration of supply and distribution networks is taking place. This recovery will assist in boosting stereotactic planning software market sales.
“Surge in neurological diseases like Alzheimer and migraine especially in geriatric population creates financial burdened the healthcare system as well as the patients. To prevent the rising prevalence of neurological disorder, the demand for stereotactic planning software analysis will reducet,” says the FMI analyst
For more Insights into the Market, Request a Sample of this Report https://www.futuremarketinsights.com/reports/sample/rep-gb-6452
Key Takeaways
Competitive Landscape
According to the study by Future Market Insights, the main area of focus among all market players is performing merger, acquisition and strategic collaboration with leading manufacturing companies to expand their market foothold and cater the demand of ever increasing patient pool.
Market players are establishing production and manufacturing facilities across the globe to penetrate new markets and leverage the unique conditions of the market.
Some of the leading companies operating in the planning software spending analysis market are:
We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6452
More Insights on the Global Stereotactic Planning Software Spending Analysis Market
Future Market Insights, in its new offering, provides an unbiased analysis of the stereotactic planning software spending analysis market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the stereotactic planning software spending analysis market with a detailed segmentation on the basis of
By Solution Type:
By Imaging Modality:
By End User:
By Region:
Key Questions Covered in the Report
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/6452
The post Demand for Precise and Effective Treatment Accelerating Stereotactic Planning Software Spending Analysis Market Growth: FMI first appeared on Market Research Blog.
The article discusses the growth of the stereotactic planning software market driven by demand for precise treatments and neurological disorder prevalence.
The U.S. is expected to account for 82% of the North America market by 2031 due to high healthcare spending and neurological disorder cases.
China's market growth is driven by an increase in stroke-related deaths and demand for advanced treatment solutions.
Explore more articles in the Research Reports category











